October 1st 2024
Regulators, EMA and HMA, have published principles and recommendations on the use of LLMs, which are being increasingly used for daily tasks.
December 2nd 2023
FDA and industry face unprecedented political and policy challenges.
August 2nd 2023
Manufacturer lawsuits prompt CMS to [slightly] modify pricing plan.
July 2nd 2023
Problems continue despite actions by regulators to better prevent and address drug shortages.
June 2nd 2023
An increase in applications for gene therapies is putting stress on FDA’s resources.